Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Selective high-affinity polydentate ligands and methods of making such

Patent ·
OSTI ID:1093436

This invention provides polydentate selective high affinity ligands (SHALs) that can be used in a variety of applications in a manner analogous to the use of antibodies. SHALs typically comprise a multiplicity of ligands that each binds different regions on the target molecule. The ligands are joined directly or through a linker thereby forming a polydentate moiety that typically binds the target molecule with high selectivity and avidity.

Research Organization:
LLNL (Lawrence Livermore National Laboratory (LLNL), Livermore, CA (United States))
Sponsoring Organization:
USDOE
DOE Contract Number:
W-7405-ENG-48
Assignee:
Lawrence Livermore National Security, LLC. (Livermore, CA); The Regents of the University of California (Oakland, CA)
Patent Number(s):
8,536,133
Application Number:
12/642,684
OSTI ID:
1093436
Country of Publication:
United States
Language:
English

References (18)

Direct Antilymphoma Activity of Novel, First-Generation "Antibody Mimics" that Bind HLA-DR10-Positive Non-Hodgkin's Lymphoma Cells journal December 2006
Humanization and characterization of the anti-HLA-DR antibody 1D10 journal January 2001
AB5 toxins: structures and inhibitor design journal December 2000
Spanning binding sites on allosteric proteins with polymer-linked ligand dimers journal October 1998
Hexa-arginine enhanced uptake and residualization of selective high affinity ligands by Raji lymphoma cells journal January 2009
Update: Systemic Radiotherapy Can Cure Lymphoma: A Paradigm for Other Malignancies? journal August 2008
Structure-Based Design of a Bispecific Receptor Mimic That Inhibits T Cell Responses to a Superantigen journal April 2001
Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors journal November 1998
Bioaffinity NMR Spectroscopy: Identification of an E-Selectin Antagonist in a Substance Mixture by Transfer NOE journal January 1999
Selective High-Affinity Ligand Antibody Mimics for Cancer Diagnosis and Therapy: Initial Application to Lymphoma/Leukemia journal September 2007
Identification of Novel Small Molecules That Bind to Two Different Sites on the Surface of Tetanus Toxin C Fragment journal October 2002
Characteristics of dimeric (bis) bidentate selective high affinity ligands as HLA-DR10 beta antibody mimics targeting non-Hodgkin's lymphoma journal October 2007
Discovering High-Affinity Ligands for Proteins: SAR by NMR journal November 1996
Disruption of Anthrax Toxin Binding with the Use of Human Antibodies and Competitive Inhibitors journal June 1999
Nanomolecular HLA-DR10 Antibody Mimics: A Potent System for Molecular Targeted Therapy and Imaging journal December 2008
Pharmacokinetic Characterization in Xenografted Mice of a Series of First-Generation Mimics for HLA-DR Antibody, Lym-1, as Carrier Molecules to Image and Treat Lymphoma journal August 2007
Lead discovery using molecular docking journal August 2002
Synthesis and Radiolabeling of Selective High-Affinity Ligands Designed to Target Non-Hodgkin's Lymphoma and Leukemia journal May 2007